Agilon Health Shares Drop 2% After January PPI Inflation Exceeds Forecasts
Agilon Health shares fell 2% after January's Producer Price Index rose 0.5%, surpassing forecasts of 0.3% and stoking concerns over delayed Federal Reserve rate cuts. The stock, trading at $0.59 per share, has seen 82 moves over 5% in the past year and is down 12% year-to-date.
1. Inflation-Driven Share Decline
Shares of Agilon Health fell 2% after the Producer Price Index increased by 0.5% in January versus forecasts of 0.3%, raising concerns that Federal Reserve interest rate cuts may be pushed further into the future.
2. High Volatility Profile
The stock has experienced 82 moves greater than 5% over the past year, reflecting its pronounced sensitivity to macroeconomic data and market sentiment.
3. Recent Quarterly Performance
In the fourth quarter of 2025, Agilon Health reported revenue of $1.57 billion, up 3.1% year-over-year and above analysts' estimates, but posted a GAAP loss of $0.46 per share and guided first-quarter 2026 revenue of $1.37 billion, below consensus.
4. Year-to-Date and Long-Term Trend
At $0.59 per share, the stock is down 12% year-to-date and trading 89.6% below its 52-week high of $5.68, and a $1,000 investment at its April 2021 IPO is now worth about $19.